Influenza vaccine from the US manufacturer seqirus USA, INC
Ended Awarded Last action
- Contract number
- 75N90020A00004
- Awardee
-
Seqirus USA Inc. UEI N6U7P2B9VHS5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $1,421,387 obligated
Award facts
- Combined order value
- $1,421,387 Current and potential, with all options
- Last date to order 100% complete
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health Clinical Center awarded Seqirus USA Inc. multiple blanket purchase agreement calls against the Pharmaceuticals and Drugs Federal Supply Schedule to provide influenza vaccines. The BPAs have a combined value of over $1.5M and require delivery of vaccines through April 2025. Seqirus will supply vaccines from domestic manufacturing facilities in Summit, New Jersey and King of Prussia, Pennsylvania to meet the Clinical Center's needs. No set-aside provisions were specified in the awards. The vaccine products include quadrivalent influenza virus vaccines in pre-filled syringes and other unspecified pharmaceuticals. These BPAs support the NIH Clinical Center's patient care and medical research missions by ensuring reliable domestic sourcing of influenza vaccines over multiple flu seasons. Seqirus USA Inc. serves as the prime contractor without use of major subcontractors.
The blanket purchase agreement calls against the GSA Pharmaceuticals and Drugs schedule provide a contracting mechanism for the NIH Clinical Center to efficiently order influenza vaccines and other pharmaceuticals on an as-needed basis. By establishing delivery terms, pricing, and sources of supply through the BPA awards to Seqirus, the Clinical Center aims to streamline procurement activities while maintaining domestic manufacturing capabilities critical to its patient and research operations.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Modification | $0 | |
| Other Administrative Action | $0 |
Quick answers
Who was awarded contract 75N90020A00004?
75N90020A00004 was awarded to Seqirus USA Inc. by NIH Clinical Center (National Institutes of Health) on April 27, 2020.
How much is contract 75N90020A00004 worth?
Orders under 75N90020A00004 have obligated $1,421,387.
How many orders have been placed under contract 75N90020A00004?
5 orders have been placed under 75N90020A00004, the latest on January 24, 2022.
Who can order from contract 75N90020A00004?
75N90020A00004 is a multiple award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75N90020A00004 under another contract?
Yes. 75N90020A00004 is a blanket purchase agreement under V797D70074, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90020A00004 competed?
The extent of competition for 75N90020A00004 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV